Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, reports the publication of a manuscript in the journal Science, which articulates a framework for the integration of advanced transcriptomic datasets and AI models to improve drug discovery.
A framework for the discovery of cell state-correcting medicines
